首页 > 最新文献

Revista de Patologia Respiratoria最新文献

英文 中文
Broncoscopia en cáncer de pulmón. ¿Hacia dónde vamos? 肺癌的治疗。我们要去哪里?
Q4 Medicine Pub Date : 2011-10-01 DOI: 10.1016/S1576-9895(11)70121-7
R. García Luján , E. de Miguel Poch
{"title":"Broncoscopia en cáncer de pulmón. ¿Hacia dónde vamos?","authors":"R. García Luján , E. de Miguel Poch","doi":"10.1016/S1576-9895(11)70121-7","DOIUrl":"10.1016/S1576-9895(11)70121-7","url":null,"abstract":"","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"14 4","pages":"Pages 109-111"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(11)70121-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rentabilidad diagnóstica de la broncoscopia en la enfermedad neoplásica en la Unidad de Fibrobroncoscopias del Hospital General Universitario de Albacete 阿尔巴塞特大学综合医院纤维支气管镜科肿瘤疾病支气管镜的诊断盈利能力
Q4 Medicine Pub Date : 2011-10-01 DOI: 10.1016/S1576-9895(11)70123-0
F.J. Callejas González, S. García Castillo, R. Godoy Mayoral, M.A. Moscardó Orenes, J. Cruz Ruiz, M. Plenc Ziegler, J. Jiménez López, R. Sánchez Simón-Talero, A. Núñez Ares, M. Vizcaya Sánchez

Background

Lung cancer is the second leading cause of mortality after cardiovascular diseases. Bronchogenic carcinoma has a fundamental underlying cause, that is, tobacco. The bronchoscopy is required for lung cancer diagnosis and staging and will help us to estimate prognosis and determine the therapeutic approach to follow. In this study, the yield of the various techniques of bronchoscopy in the diagnosis of lung cancer has been analyzed.

Methods

Previous comorbidity, smoking habit, the different bronchoscopic techniques the subject underwent and the patient's TNM stage at the time of diagnosis were analyzed in 181 patients who underwent bronchoscopy and whose final diagnosis was neoplasm. The performance of our techniques in relation to other studies in the literature was also evaluated.

Results

A total of 86.2% of patients had a history of smoking, 49.2%, diagnosis of Chronic obstruction pulmonary disease and 18.9% had had another previous malignancy. The endoscopic examination showed endobronchial lesion in 58% of patients. BAS was positive in 53.6% of procedures performed, bronchial biopsy 81.9%, transbronchial biopsy in 71.8% (in association with positive fluoroscopy in 81% and without fluoroscopy in 61% of cases) and positive transbronchial needle aspiration in 64.3% (with pathologist present the diagnostic yield amounted to 72.7%).

Conclusions

The yield of bronchoscopic techniques used in our environment is similar to that found in other major studies conducted to date.

肺癌是仅次于心血管疾病的第二大死亡原因。支气管癌有一个根本的潜在原因,那就是烟草。支气管镜检查是肺癌诊断和分期所必需的,它将帮助我们估计预后和确定治疗方法。在本研究中,分析了各种支气管镜检查技术在肺癌诊断中的效果。方法对181例经支气管镜检查最终诊断为肿瘤的患者的既往合并症、吸烟习惯、不同的支气管镜检查方法及诊断时患者的TNM分期进行分析。我们的技术与文献中其他研究的表现也进行了评估。结果86.2%的患者有吸烟史,49.2%的患者诊断为慢性阻塞性肺疾病,18.9%的患者既往有其他恶性肿瘤。内镜检查显示58%的患者有支气管内病变。在53.6%的手术中,BAS呈阳性,支气管活检为81.9%,经支气管活检为71.8%(与81%的透视阳性和61%的无透视病例相关),经支气管穿刺阳性为64.3%(有病理学家在场,诊断率为72.7%)。结论:在我们的环境中使用的支气管镜技术的产量与迄今为止进行的其他主要研究中发现的相似。
{"title":"Rentabilidad diagnóstica de la broncoscopia en la enfermedad neoplásica en la Unidad de Fibrobroncoscopias del Hospital General Universitario de Albacete","authors":"F.J. Callejas González,&nbsp;S. García Castillo,&nbsp;R. Godoy Mayoral,&nbsp;M.A. Moscardó Orenes,&nbsp;J. Cruz Ruiz,&nbsp;M. Plenc Ziegler,&nbsp;J. Jiménez López,&nbsp;R. Sánchez Simón-Talero,&nbsp;A. Núñez Ares,&nbsp;M. Vizcaya Sánchez","doi":"10.1016/S1576-9895(11)70123-0","DOIUrl":"10.1016/S1576-9895(11)70123-0","url":null,"abstract":"<div><h3>Background</h3><p>Lung cancer is the second leading cause of mortality after cardiovascular diseases. Bronchogenic carcinoma has a fundamental underlying cause, that is, tobacco. The bronchoscopy is required for lung cancer diagnosis and staging and will help us to estimate prognosis and determine the therapeutic approach to follow. In this study, the yield of the various techniques of bronchoscopy in the diagnosis of lung cancer has been analyzed.</p></div><div><h3>Methods</h3><p>Previous comorbidity, smoking habit, the different bronchoscopic techniques the subject underwent and the patient's TNM stage at the time of diagnosis were analyzed in 181 patients who underwent bronchoscopy and whose final diagnosis was neoplasm. The performance of our techniques in relation to other studies in the literature was also evaluated.</p></div><div><h3>Results</h3><p><span>A total of 86.2% of patients had a history of smoking, 49.2%, diagnosis of Chronic obstruction pulmonary disease and 18.9% had had another previous malignancy. The endoscopic examination showed endobronchial lesion in 58% of patients. BAS was positive in 53.6% of procedures performed, bronchial biopsy 81.9%, transbronchial biopsy in 71.8% (in association with positive </span>fluoroscopy<span><span> in 81% and without fluoroscopy in 61% of cases) and positive transbronchial needle aspiration in 64.3% (with </span>pathologist present the diagnostic yield amounted to 72.7%).</span></p></div><div><h3>Conclusions</h3><p>The yield of bronchoscopic techniques used in our environment is similar to that found in other major studies conducted to date.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"14 4","pages":"Pages 117-123"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(11)70123-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Enfermedad de Castleman: dos variantes, dos pacientes Castleman病:两种变异,两名患者
Q4 Medicine Pub Date : 2011-10-01 DOI: 10.1016/S1576-9895(11)70126-6
K. de Aguiar Quevedo , C. Jordá Aragón , N. Mancheño Franch , G. Sales Badía , V. Calvo Medina , A. García Zarza , J. Pastor Guillén

Introduction

Castleman's disease (CD) is an uncommon lymphoproliferative disorder most frequently localized in the mediastinum and abdomen.

Two cases of CD with mediastinal localization in our service are described. The first case was found in a 33-year old woman with the plasma cell variant of CD associated to Hodgkin's disease and the second case was found in a 32 year old woman with hyalinevascular type CD.

Discussion

CD, of unknown etiology, is clinically distinguished with two forms, multicentric that affects more than one organ and occurs with general symptoms and can be accompanied by other involvements such as lymphoma. The second one is the localized one, which is more frequent and evolves asymptomatically or with compressive symptoms due to mass effect. In these cases presented, the difference in the clinical presentation of this condition in its two variants can be seen.

Conclusions

CD is an uncommon lymphoproliferative disease whose treatment is tumor resection and whose prognosis is good.

castleman病(CD)是一种罕见的淋巴细胞增生性疾病,最常见于纵隔和腹部。本文描述了两例纵膈定位的乳糜泻。第一例发现于一名患有与霍奇金病相关的CD浆细胞变异的33岁女性,第二例发现于一名32岁的透明血管型CD的女性。病因不明的CD在临床上有两种形式,多中心,影响多个器官,发生一般症状,可伴有其他累及,如淋巴瘤。第二种是局部性,较常见,因质量效应而无症状发展或有压缩症状。在这些病例中,可以看到这种情况在其两种变体的临床表现的差异。结论scd是一种少见的淋巴细胞增生性疾病,治疗方法为肿瘤切除,预后良好。
{"title":"Enfermedad de Castleman: dos variantes, dos pacientes","authors":"K. de Aguiar Quevedo ,&nbsp;C. Jordá Aragón ,&nbsp;N. Mancheño Franch ,&nbsp;G. Sales Badía ,&nbsp;V. Calvo Medina ,&nbsp;A. García Zarza ,&nbsp;J. Pastor Guillén","doi":"10.1016/S1576-9895(11)70126-6","DOIUrl":"10.1016/S1576-9895(11)70126-6","url":null,"abstract":"<div><h3>Introduction</h3><p>Castleman's disease (CD) is an uncommon lymphoproliferative disorder most frequently localized in the mediastinum and abdomen.</p><p>Two cases of CD with mediastinal localization in our service are described. The first case was found in a 33-year old woman with the plasma cell variant of CD associated to Hodgkin's disease and the second case was found in a 32 year old woman with hyalinevascular type CD.</p></div><div><h3>Discussion</h3><p>CD, of unknown etiology, is clinically distinguished with two forms, multicentric that affects more than one organ and occurs with general symptoms and can be accompanied by other involvements such as lymphoma. The second one is the localized one, which is more frequent and evolves asymptomatically or with compressive symptoms due to mass effect. In these cases presented, the difference in the clinical presentation of this condition in its two variants can be seen.</p></div><div><h3>Conclusions</h3><p>CD is an uncommon lymphoproliferative disease whose treatment is tumor resection and whose prognosis is good.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"14 4","pages":"Pages 138-142"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(11)70126-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Aportación europea a la especialidad de cirugía torácica. Contribución de los países del continente 欧洲对胸外科专业的贡献。非洲大陆各国的贡献
Q4 Medicine Pub Date : 2011-10-01 DOI: 10.1016/S1576-9895(11)70124-2
F. París Romeu , J.L. Bravo Bravo

In previous works, we have analyzed the German and British contribution to general Thoracic Surgery and then we developed what had been occurring during the same time in the rest of Europe. We will examine the lack of a Professional Society suitable for the development of Thoracic Surgery, in spite of the existence of surgeons who had begun to develop novel techniques during these years. In the north of Europe, Thoracic Surgery had been initiated with Dr. Jacobeus of Stockholm. In the Netherlands, the first pneumonectomy was performed due to a picture of bronchiectasis in the year 1940. During that time, surgical treatment was performed in approximately 1200 patients suffering tuberculosis conditions with approximately 2% surgical mortality. The contribution in Belgium evolved favorably after the year 1930 and there was a subsequent separation of General and Digestive Surgery from Cardiac, Osteoarticular, Urology and Neurosurgery. In 1970, when extrafascial plombage with fat was begun, Dr. LeBrigand contributed new techniques for treatment of tuberculosis and in thoracic traumas and tracheal-bronchial lesions. Meanwhile, in Marcela, the first practices of bronchographies were conducted and works on experimental lung transplants were begun. The contribution of Iberia and of Italian Surgery were collected in Spain with names such as Dr. González Duarte or Gil Turner and the Italian participation was fundamentally begun between the years 1,900 and 1,976 with the performance of pulmonary and esophageal surgery, standing out, among others, Dr. Erino A Rendina. In Austria, they began with colapsotherapy, performing thoracoplasties, artificial pneumothorax and phrenicectomies. In Turkey and in Greece, the equinococosis was a serious health problem and many techniques were developed for its treatment. Similarly, distal esophageal fundoplications were performed and Antalaya School of Thoracic Surgery was developed. It has been difficult to gather data in regards to the said area of the Eastern Bloc. Until the Berlin Wall fell, the problem was to find reliable sources of information. It was in those countries in which pulmonary surgery was developed and in which esophageal surgical was assimilated. Thus, in the 1930's, the mediastinal approach through the abdomen was proposed and thoracic esophageal-gastric anastomeses were performed by Uglov. Finally, we point out that the School of St. Petersburg is considered as the representative of the surgery of the Russian Federation and in which important periods of development were begun, which have been included in our current bibliographic citations.

在之前的工作中,我们分析了德国和英国对普通胸外科的贡献,然后我们发展了同一时期欧洲其他国家的情况。尽管近年来已经有外科医生开始发展新技术,但我们将研究缺乏适合胸外科发展的专业协会。在北欧,斯德哥尔摩的雅各布博士开创了胸外科。在荷兰,由于支气管扩张的照片,于1940年进行了第一次全肺切除术。在此期间,约有1200名结核病患者接受了手术治疗,手术死亡率约为2%。1930年后,比利时的贡献得到了有利的发展,随后将普通外科和消化外科从心脏外科、骨关节外科、泌尿外科和神经外科中分离出来。1970年,当开始筋膜外脂肪填充术时,LeBrigand博士为治疗肺结核、胸部创伤和气管支气管病变贡献了新技术。与此同时,在马赛拉,进行了第一次支气管造影,并开始了实验性肺移植的工作。伊比利亚和意大利外科的贡献在西班牙收集,其名字如González Duarte博士或Gil Turner博士,意大利的参与基本上是在1900年至1976年之间开始的,其中最突出的是Erino A Rendina博士的肺和食管手术。在奥地利,他们开始进行塌陷治疗,进行胸腔成形术、人工气胸和膈切除术。在土耳其和希腊,马癣是一个严重的健康问题,为此开发了许多治疗方法。类似地,远端食道手术也进行了,并开发了Antalaya胸外科学校。很难收集有关上述东方集团地区的数据。在柏林墙倒塌之前,问题是找到可靠的信息来源。就是在那些发展了肺外科和吸收了食管外科的国家。因此,在20世纪30年代,提出了通过腹部的纵隔入路,并由Uglov进行了胸椎食管胃吻合。最后,我们指出,圣彼得堡学派被认为是俄罗斯联邦外科手术的代表,并在其中开始了重要的发展时期,这些时期已列入我们目前的书目引文中。
{"title":"Aportación europea a la especialidad de cirugía torácica. Contribución de los países del continente","authors":"F. París Romeu ,&nbsp;J.L. Bravo Bravo","doi":"10.1016/S1576-9895(11)70124-2","DOIUrl":"10.1016/S1576-9895(11)70124-2","url":null,"abstract":"<div><p>In previous works, we have analyzed the German and British contribution to general Thoracic Surgery and then we developed what had been occurring during the same time in the rest of Europe. We will examine the lack of a Professional Society suitable for the development of Thoracic Surgery, in spite of the existence of surgeons who had begun to develop novel techniques during these years. In the north of Europe, Thoracic Surgery had been initiated with Dr. Jacobeus of Stockholm. In the Netherlands, the first pneumonectomy was performed due to a picture of bronchiectasis in the year 1940. During that time, surgical treatment was performed in approximately 1200 patients suffering tuberculosis conditions with approximately 2% surgical mortality. The contribution in Belgium evolved favorably after the year 1930 and there was a subsequent separation of General and Digestive Surgery from Cardiac, Osteoarticular, Urology and Neurosurgery. In 1970, when extrafascial plombage with fat was begun, Dr. LeBrigand contributed new techniques for treatment of tuberculosis and in thoracic traumas and tracheal-bronchial lesions. Meanwhile, in Marcela, the first practices of bronchographies were conducted and works on experimental lung transplants were begun. The contribution of Iberia and of Italian Surgery were collected in Spain with names such as Dr. González Duarte or Gil Turner and the Italian participation was fundamentally begun between the years 1,900 and 1,976 with the performance of pulmonary and esophageal surgery, standing out, among others, Dr. Erino A Rendina. In Austria, they began with colapsotherapy, performing thoracoplasties, artificial pneumothorax and phrenicectomies. In Turkey and in Greece, the equinococosis was a serious health problem and many techniques were developed for its treatment. Similarly, distal esophageal fundoplications were performed and Antalaya School of Thoracic Surgery was developed. It has been difficult to gather data in regards to the said area of the Eastern Bloc. Until the Berlin Wall fell, the problem was to find reliable sources of information. It was in those countries in which pulmonary surgery was developed and in which esophageal surgical was assimilated. Thus, in the 1930's, the mediastinal approach through the abdomen was proposed and thoracic esophageal-gastric anastomeses were performed by Uglov. Finally, we point out that the School of St. Petersburg is considered as the representative of the surgery of the Russian Federation and in which important periods of development were begun, which have been included in our current bibliographic citations.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"14 4","pages":"Pages 124-134"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(11)70124-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mujer con pulmón del cuidador de aves 有肺的女人照顾鸟
Q4 Medicine Pub Date : 2011-07-01 DOI: 10.1016/S1576-9895(11)70116-3
R.M. Gómez Punter, E. Vázquez Espinosa, R.M. Girón, J.A. García Romero de Tejada, G.M. Fernándes, G. Segrelles, E. Zamora

Hypersensitivity pneumonitis or extrinsic allergic alveolitis (EAA) originates from a hypersensitivity reaction to inhaled antigens on a lung with individual susceptibility. In the case of bird breeder's lung, they are particles that are generally found on the epithelium, dust that covers the feathers or stools of the birds.

In the physical examination, the inspiratory crackling rales heard on pulmonary auscultations stand out and the findings on the chest X-ray may vary greatly. The CT scan shows us different patterns based on the disease phase in question. Regarding the pulmonary function tests, most of the patients have a restrictive pattern.

Early diagnosis is crucial in the disease course since progression may lead to pulmonary fibrosis or chronic obstructive pulmonary disease.

The most important is to eliminate exposition to the antigens, with which many patients recover.

过敏性肺炎或外源性过敏性肺泡炎(EAA)起源于对个体易感性的肺部吸入抗原的超敏反应。在鸟类饲养者肺的情况下,它们是通常在上皮上发现的颗粒,覆盖鸟类羽毛或粪便的灰尘。在体格检查中,肺听诊中听到的吸气式爆裂声很突出,胸片上的表现可能差异很大。CT扫描显示了不同疾病阶段的不同模式。在肺功能检查中,多数患者为限制性型。早期诊断对病程至关重要,因为病程进展可能导致肺纤维化或慢性阻塞性肺疾病。最重要的是消除对抗原的接触,许多病人都能康复。
{"title":"Mujer con pulmón del cuidador de aves","authors":"R.M. Gómez Punter,&nbsp;E. Vázquez Espinosa,&nbsp;R.M. Girón,&nbsp;J.A. García Romero de Tejada,&nbsp;G.M. Fernándes,&nbsp;G. Segrelles,&nbsp;E. Zamora","doi":"10.1016/S1576-9895(11)70116-3","DOIUrl":"10.1016/S1576-9895(11)70116-3","url":null,"abstract":"<div><p>Hypersensitivity pneumonitis or extrinsic allergic alveolitis (EAA) originates from a hypersensitivity reaction to inhaled antigens on a lung with individual susceptibility. In the case of bird breeder's lung, they are particles that are generally found on the epithelium, dust that covers the feathers or stools of the birds.</p><p>In the physical examination, the inspiratory crackling rales heard on pulmonary auscultations stand out and the findings on the chest X-ray may vary greatly. The CT scan shows us different patterns based on the disease phase in question. Regarding the pulmonary function tests, most of the patients have a restrictive pattern.</p><p>Early diagnosis is crucial in the disease course since progression may lead to pulmonary fibrosis or chronic obstructive pulmonary disease.</p><p>The most important is to eliminate exposition to the antigens, with which many patients recover.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"14 3","pages":"Pages 92-96"},"PeriodicalIF":0.0,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(11)70116-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diseminación hematógena y neumonitis por el bacilo de Calmette-Guérin calmette - guerin杆菌的血源性传播和肺炎
Q4 Medicine Pub Date : 2011-07-01 DOI: 10.1016/S1576-9895(11)70117-5
G. García García , A. Ortiz Cansado , M.C. García García , F. García de la Llana

Intravesical administration of Bacille Calmette-Guérin (BCG) may cause local and systemic infectious complications. Systemic complications are rare but very serious. We report the case of a man with such treatment who began with fever what was initially attributed to a urological sepsis. After, hematogenous dissemination and pneumonitis were suspected, these being diagnosed by gallium-67 scintigraphy. In addition, Mycobacterium bovis was isolated in the urine.

卡介苗(Bacille calmette - gusamrin, BCG)经膀胱注射可引起局部和全身感染并发症。全身并发症很少见,但非常严重。我们报告的情况下,一个人与这种治疗谁开始发烧,最初归因于泌尿败血症。之后,怀疑血液播散和肺炎,这些被诊断为镓-67显像。此外,在尿中分离到牛分枝杆菌。
{"title":"Diseminación hematógena y neumonitis por el bacilo de Calmette-Guérin","authors":"G. García García ,&nbsp;A. Ortiz Cansado ,&nbsp;M.C. García García ,&nbsp;F. García de la Llana","doi":"10.1016/S1576-9895(11)70117-5","DOIUrl":"10.1016/S1576-9895(11)70117-5","url":null,"abstract":"<div><p>Intravesical administration of Bacille Calmette-Guérin (BCG) may cause local and systemic infectious complications. Systemic complications are rare but very serious. We report the case of a man with such treatment who began with fever what was initially attributed to a urological sepsis. After, hematogenous dissemination and pneumonitis were suspected, these being diagnosed by gallium-67 scintigraphy. In addition, <em>Mycobacterium bovis</em> was isolated in the urine.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"14 3","pages":"Pages 97-99"},"PeriodicalIF":0.0,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(11)70117-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
¿Qué saben los pacientes adultos con fibrosis quística de su enfermedad? Adherencia al tratamiento 成年囊性纤维化患者对他们的疾病了解多少?治疗依从性
Q4 Medicine Pub Date : 2011-07-01 DOI: 10.1016/S1576-9895(11)70114-X
I. Lucena, J. Olivares, C. Prados, E. Martínez-Cerón, A. Pérez, L. Gómez Carrera, J.J. Cabanillas, R. Álvarez-Sala

Introduction

Cystic fibrosis (CF) has an increased of the survival due to the multidisciplinary advance. We have proposed to discover if the patients of the Unit of adults of CF know and fulfill their usual treatment, with the aim of seeing what level of knowledge they have their disease and its implications.

Material and methods

We have carried out a simple blind, cross-sectional descriptive study, with ordinal qualitative variable in an adult CF Unit who answered a questionnaire in which they were asked about the treatment of the disease and its administration, toxic habits, knowledge of their disease and concern about their present or future.

Results

The questionnaire was answered by 35 (40%) during the years 2000–2001, with a mean age of 31.43 ± 8.49 years. When asked about their knowledge of the disease, 94.3% (33 patients) considered they were informed about it and 91.4% (32 patients) said the information was adequate. What concerned them the most was the deterioration of their quality of life (14.3%-5 patients), concern about the future (11.4%-4 patients), the limitations in their daily life (8.6%-3 patients) and mortality or having recurrences (2.9%-1 patient). Four patients (11.4%) did not answer this question.

Conclusions

most of the patients who answered the survey knew about their disease, its treatment and were clear about their concerns for the future. However, less than half of all the patients answered, which indicates that more investigations are necessary to find the causes of this problem.

由于多学科的进步,囊性纤维化(CF)的生存率有所提高。我们建议了解成人CF单元的患者是否了解并完成了他们的常规治疗,目的是了解他们对自己的疾病及其影响的了解程度。材料和方法我们在一名成年CF患者中进行了一项简单盲、横断面描述性研究,采用顺序定性变量,他们回答了一份问卷,其中询问了他们对疾病的治疗和给药、中毒习惯、对疾病的了解以及对他们现在或未来的担忧。结果2000-2001年共接受问卷调查35例(40%),平均年龄31.43±8.49岁。当被问及他们对该疾病的了解时,94.3%(33名患者)认为他们被告知,91.4%(32名患者)表示信息足够。他们最担心的是生活质量恶化(14.3%-5例)、对未来的担忧(11.4%-4例)、日常生活受限(8.6%-3例)和死亡或复发(2.9%-1例)。4例患者(11.4%)未回答此问题。大多数接受调查的患者了解自己的疾病、治疗方法,并清楚自己对未来的担忧。但是,只有不到一半的患者回答了这个问题,这表明需要进行更多的调查,以找出这个问题的原因。
{"title":"¿Qué saben los pacientes adultos con fibrosis quística de su enfermedad? Adherencia al tratamiento","authors":"I. Lucena,&nbsp;J. Olivares,&nbsp;C. Prados,&nbsp;E. Martínez-Cerón,&nbsp;A. Pérez,&nbsp;L. Gómez Carrera,&nbsp;J.J. Cabanillas,&nbsp;R. Álvarez-Sala","doi":"10.1016/S1576-9895(11)70114-X","DOIUrl":"10.1016/S1576-9895(11)70114-X","url":null,"abstract":"<div><h3>Introduction</h3><p>Cystic fibrosis (CF) has an increased of the survival due to the multidisciplinary advance. We have proposed to discover if the patients of the Unit of adults of CF know and fulfill their usual treatment, with the aim of seeing what level of knowledge they have their disease and its implications.</p></div><div><h3>Material and methods</h3><p>We have carried out a simple blind, cross-sectional descriptive study, with ordinal qualitative variable in an adult CF Unit who answered a questionnaire in which they were asked about the treatment of the disease and its administration, toxic habits, knowledge of their disease and concern about their present or future.</p></div><div><h3>Results</h3><p>The questionnaire was answered by 35 (40%) during the years 2000–2001, with a mean age of 31.43<!--> <!-->±<!--> <!-->8.49 years. When asked about their knowledge of the disease, 94.3% (33 patients) considered they were informed about it and 91.4% (32 patients) said the information was adequate. What concerned them the most was the deterioration of their quality of life (14.3%-5 patients), concern about the future (11.4%-4 patients), the limitations in their daily life (8.6%-3 patients) and mortality or having recurrences (2.9%-1 patient). Four patients (11.4%) did not answer this question.</p></div><div><h3>Conclusions</h3><p>most of the patients who answered the survey knew about their disease, its treatment and were clear about their concerns for the future. However, less than half of all the patients answered, which indicates that more investigations are necessary to find the causes of this problem.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"14 3","pages":"Pages 78-82"},"PeriodicalIF":0.0,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(11)70114-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ventilación mecánica y traqueotomía. Protocolo de destete de ventilación mecánica y decanulación de la Unidad de Cuidados Respiratorios Intermedios de la Fundación Jiménez Díaz 机械通气和气管切开术。jimenez diaz基金会中间呼吸护理单元机械通气断奶和取消的协议
Q4 Medicine Pub Date : 2011-07-01 DOI: 10.1016/S1576-9895(11)70115-1
S.B. Heili Frades , G. Peces Barba Romero , M. Villar , S. Pelicano , M.J. Checa Venegas , R. Gutiérrez Fonseca , O. Sánchez Villa

This article presents a decanulation protocol procedure for difficult to wean patients from the intensive care units in whom mechanical ventilation weaning has not been possible, and left this units needing invasive mechanical ventilation and tracheotomy. The appearance of the socalled Intermediate Respiratory Units allow pulmonologists, specialized in critical care medicine to treat these patients as those units deal with upper airway management, artificial invasive and non invasive mechanical ventilation and respiratory endoscopy. Our Pulmonology service include an intermediate respiratory unit and have wide experience in weaning patients from mechanical ventilation and subsequent decanulation. At present, no article in the literature globally explains the management of these patients. We present the protocol we follow in our unit with which we have obtained very favorable results in this type of patient.

本文介绍了一种脱管方案程序,用于难以脱离重症监护病房的患者,在这些患者中,机械通气无法脱离,并且需要有创机械通气和气管切开术。所谓的中间呼吸单元的出现,使专门从事重症监护医学的肺科医生能够治疗这些患者,因为这些单元处理上呼吸道管理,人工侵入性和非侵入性机械通气以及呼吸内窥镜检查。我们的肺科服务包括一个中间呼吸单元,并在脱离机械通气和随后的脱管患者方面拥有丰富的经验。目前,全球文献中没有一篇文章解释了这些患者的管理。我们提出的方案,我们遵循在我们的单位,我们已经获得了非常有利的结果,在这类患者。
{"title":"Ventilación mecánica y traqueotomía. Protocolo de destete de ventilación mecánica y decanulación de la Unidad de Cuidados Respiratorios Intermedios de la Fundación Jiménez Díaz","authors":"S.B. Heili Frades ,&nbsp;G. Peces Barba Romero ,&nbsp;M. Villar ,&nbsp;S. Pelicano ,&nbsp;M.J. Checa Venegas ,&nbsp;R. Gutiérrez Fonseca ,&nbsp;O. Sánchez Villa","doi":"10.1016/S1576-9895(11)70115-1","DOIUrl":"10.1016/S1576-9895(11)70115-1","url":null,"abstract":"<div><p>This article presents a decanulation protocol procedure for difficult to wean patients from the intensive care units in whom mechanical ventilation weaning has not been possible, and left this units needing invasive mechanical ventilation and tracheotomy. The appearance of the socalled Intermediate Respiratory Units allow pulmonologists, specialized in critical care medicine to treat these patients as those units deal with upper airway management, artificial invasive and non invasive mechanical ventilation and respiratory endoscopy. Our Pulmonology service include an intermediate respiratory unit and have wide experience in weaning patients from mechanical ventilation and subsequent decanulation. At present, no article in the literature globally explains the management of these patients. We present the protocol we follow in our unit with which we have obtained very favorable results in this type of patient.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"14 3","pages":"Pages 83-91"},"PeriodicalIF":0.0,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(11)70115-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Pirfenidona: una puerta abierta a la esperanza en la fibrosis pulmonar idiopática 吡非尼酮:特发性肺纤维化的希望之门
Q4 Medicine Pub Date : 2011-07-01 DOI: 10.1016/S1576-9895(11)70112-6
C. Valenzuela, J. Ancochea
{"title":"Pirfenidona: una puerta abierta a la esperanza en la fibrosis pulmonar idiopática","authors":"C. Valenzuela,&nbsp;J. Ancochea","doi":"10.1016/S1576-9895(11)70112-6","DOIUrl":"10.1016/S1576-9895(11)70112-6","url":null,"abstract":"","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"14 3","pages":"Pages 67-69"},"PeriodicalIF":0.0,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(11)70112-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relación de la saturación de O2 en la prueba de los seis minutos marcha con la masa muscular y la fuerza de contracción del cuádriceps en hombres con EPOC 慢性阻塞性肺病男性6分钟步行试验中氧饱和度与肌肉质量和股四头肌收缩力的关系
Q4 Medicine Pub Date : 2011-07-01 DOI: 10.1016/S1576-9895(11)70113-8
C. Gutiérrez Ortega , F.J. Gómez de Terreros Sánchez , F.J. Gómez de Terreros Caro , L. Callol Sánchez

Hypothesis

Among the causes of muscle dysfunction in COPD, mention has been made of decreased oxygen delivery during exercise. Saturation levels during the 6 minutes walking test could be associated to muscle mass and function.

Population, material and methods

A group of 75 males patients, 48 (68.6%) males with COPD in different GOLD stages and 28 (74%) with chronic bronchitis (CB) were studied. Tests performed were spirometry, body mass composition analysis, 6 minutes walking test (6MWT), recording of mean hemoglobin saturation and greater or less than 4%, quadriceps voluntary contraction strength test (QMVC). Work performed (Ww) was determined by the Chuang equation and muscle mass by the Janssen Equation.

Results

No statistical differences were found in age, body mass index (BMI), free fat mass index (FFMI), muscle mass index (MMI) and QMVC, 6MWT and Ww between the COPD and CB groups. Desaturation  4% was more frequent in the COPD group (p < 0.01) and was related with a limitation in the distance walked (p = 0.025). The mean SpO2 after 6MWT of  89% differentiates the COPD from the CB population (p = 0.002). We found no relationship between the different levels of SpO2 after the walk test and muscle mass parameters (MMI, FFMI).

There was a statistical difference between patients with a mean SpO2 after the walk test  90% and the distance reached (p = 0.04). When the mean SpO2 was  89%, there was a decrease in the WW (p = 0.032). When the mean SpO2 was  88% we found a decrease in the QMVC (p = 0.05).

Conclusions

After the 6MWT, SpO2 is more frequent, this having no relationship with the GOLD stage and is only related with the distance reached. Mean SpO2 after the 6MWT is more sensitive since it is related to performance parameters in the first place, then with muscle strength, and later with quadriceps contraction strength. We found no relationship between the desaturation parameters studied and the muscle mass measurements.

在COPD患者肌肉功能障碍的原因中,已经提到了运动时氧气输送减少。6分钟步行测试期间的饱和水平可能与肌肉质量和功能有关。人群、材料与方法研究75例男性COPD不同GOLD期患者48例(68.6%),慢性支气管炎(CB)患者28例(74%)。试验包括肺活量测定、体质量组成分析、6分钟步行试验(6MWT)、平均血红蛋白饱和度及大于或小于4%的记录、股四头肌自主收缩强度试验(QMVC)。完成的功(Ww)由Chuang方程确定,肌肉质量由Janssen方程确定。结果COPD组与CB组在年龄、身体质量指数(BMI)、游离脂肪质量指数(FFMI)、肌肉质量指数(MMI)、QMVC、6MWT、Ww等指标上均无统计学差异。去饱和≥4%在COPD组更常见(p <0.01),并与行走距离限制有关(p = 0.025)。6MWT后SpO2均值≤89%是COPD与CB人群的鉴别指标(p = 0.002)。我们发现步行试验后不同水平的SpO2与肌肉质量参数(MMI, FFMI)之间没有关系。步行测试后SpO2均值≤90%的患者与行走距离的差异有统计学意义(p = 0.04)。平均SpO2≤89%时,WW降低(p = 0.032)。平均SpO2≤88%时,QMVC下降(p = 0.05)。结论6MWT后,SpO2发生率较高,与GOLD分期无关,仅与到达的距离有关。6MWT后的平均SpO2更敏感,它首先与性能参数有关,其次与肌肉力量有关,最后与股四头肌收缩力量有关。我们发现所研究的去饱和参数与肌肉质量测量之间没有关系。
{"title":"Relación de la saturación de O2 en la prueba de los seis minutos marcha con la masa muscular y la fuerza de contracción del cuádriceps en hombres con EPOC","authors":"C. Gutiérrez Ortega ,&nbsp;F.J. Gómez de Terreros Sánchez ,&nbsp;F.J. Gómez de Terreros Caro ,&nbsp;L. Callol Sánchez","doi":"10.1016/S1576-9895(11)70113-8","DOIUrl":"10.1016/S1576-9895(11)70113-8","url":null,"abstract":"<div><h3>Hypothesis</h3><p>Among the causes of muscle dysfunction in COPD, mention has been made of decreased oxygen delivery during exercise. Saturation levels during the 6 minutes walking test could be associated to muscle mass and function.</p></div><div><h3>Population, material and methods</h3><p>A group of 75 males patients, 48 (68.6%) males with COPD in different GOLD stages and 28 (74%) with chronic bronchitis (CB) were studied. Tests performed were spirometry, body mass composition analysis, 6 minutes walking test (6MWT), recording of mean hemoglobin saturation and greater or less than 4%, quadriceps voluntary contraction strength test (QMVC). Work performed (Ww) was determined by the Chuang equation and muscle mass by the Janssen Equation.</p></div><div><h3>Results</h3><p>No statistical differences were found in age, body mass index (BMI), free fat mass index (FFMI), muscle mass index (MMI) and QMVC, 6MWT and Ww between the COPD and CB groups. Desaturation<!--> <!-->≥<!--> <!-->4% was more frequent in the COPD group (p<!--> <!-->&lt;<!--> <!-->0.01) and was related with a limitation in the distance walked (p<!--> <!-->=<!--> <!-->0.025). The mean SpO<sub>2</sub> after 6MWT of<!--> <!-->≤<!--> <!-->89% differentiates the COPD from the CB population (p<!--> <!-->=<!--> <!-->0.002). We found no relationship between the different levels of SpO<sub>2</sub> after the walk test and muscle mass parameters (MMI, FFMI).</p><p>There was a statistical difference between patients with a mean SpO<sub>2</sub> after the walk test<!--> <!-->≤<!--> <!-->90% and the distance reached (p<!--> <!-->=<!--> <!-->0.04). When the mean SpO<sub>2</sub> was<!--> <!-->≤<!--> <!-->89%, there was a decrease in the WW (p<!--> <!-->=<!--> <!-->0.032). When the mean SpO2 was<!--> <!-->≤<!--> <!-->88% we found a decrease in the QMVC (p<!--> <!-->=<!--> <!-->0.05).</p></div><div><h3>Conclusions</h3><p>After the 6MWT, SpO<sub>2</sub> is more frequent, this having no relationship with the GOLD stage and is only related with the distance reached. Mean SpO<sub>2</sub> after the 6MWT is more sensitive since it is related to performance parameters in the first place, then with muscle strength, and later with quadriceps contraction strength. We found no relationship between the desaturation parameters studied and the muscle mass measurements.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"14 3","pages":"Pages 70-77"},"PeriodicalIF":0.0,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(11)70113-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Revista de Patologia Respiratoria
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1